Be The Match BioTherapies® to present at CAR-T Congress USA on March 22
MINNEAPOLIS — March 2018
Be The Match BioTherapies® will be exhibiting and presenting at CAR-T Congress USA: A Collaborative Approach to Maximize the Potential of CAR-T, in Boston, Mass., March 21-22, 2018.
On Thursday, Mar. 22, at 10:00 a.m., Julie Smolich, Vice President of Product Management, Be The Match BioTherapies, will participate in the panel discussion, “The Obstacles to Patient Access: What Considerations Are Needed to Overcome the Challenges of Expanding CAR-T Cell Therapy to a Global Patient Population?”.
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies. Through discussion of the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in-depth view into this expansive area.
If you’re attending the conference, visit the Be The Match BioTherapies team in the exhibit area. Or, contact us to schedule a one-on-one meeting.